Prosight Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-17,948
| Closed | -$603K | – | 36 |
|
|
2019
Q2 | $603K | Buy |
17,948
+6,935
| +63% | +$233K | 0.3% | 36 |
|
|
2019
Q1 | $584K | Sell |
11,013
-1,275
| -10% | -$67.6K | 0.26% | 33 |
|
|
2018
Q4 | $578K | Sell |
12,288
-3,957
| -24% | -$186K | 0.3% | 34 |
|
|
2018
Q3 | $1.43M | Sell |
16,245
-41,690
| -72% | -$3.67M | 0.8% | 26 |
|
|
2018
Q2 | $6.03M | Sell |
57,935
-1,383
| -2% | -$144K | 4.42% | 8 |
|
|
2018
Q1 | $4.75M | Sell |
59,318
-23,076
| -28% | -$1.85M | 2.98% | 15 |
|
|
2017
Q4 | $11.2M | Buy |
+82,394
| New | +$11.2M | 8.24% | 3 |
|